Impact of varicella vaccination in Argentina: Seroprevalence in children and adults in a pediatric hospital

• Published in: Vaccine: X Vol. 10; p. 100136
• Main Authors: Gentile, Angela, del Valle Juarez, María, Lucion, María Florencia, Pejito, María Natalia, Martínez, Ana Clara, Folino, Agostina, Viegas, Mariana, Giglio, Norberto
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.04.2022; Elsevier
• Subjects: Pediatrics; Regular paper; Seroprevalence; Varicella; Varicella vaccine; Varicella; Pediatrics; Varicella vaccine; Seroprevalence

Varicella is the primary infection caused by varicella-zoster virus (VZV). In Argentina, the varicella vaccine was introduced in the National Immunization Programme in 2015 as a single dose scheduled at 15 months of age. To estimate VZV seroprevalence in a healthy hospital based population before an...